Patricia Ann Duffy

Array ( [id] => 4338207 [patent_doc_number] => 06284221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Method for identifying .beta.-amyloid peptide production inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/733202 [patent_app_country] => US [patent_app_date] => 1996-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 12964 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284221.pdf [firstpage_image] =>[orig_patent_app_number] => 733202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880609 [patent_doc_number] => 05798219 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Serological identification of cattle, sheep or goats infected with anaplasma species' [patent_app_type] => 1 [patent_app_number] => 8/730995 [patent_app_country] => US [patent_app_date] => 1996-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1802 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798219.pdf [firstpage_image] =>[orig_patent_app_number] => 730995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024913 [patent_doc_number] => 05902590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Cosmetic and/or pharmaceutical formulations' [patent_app_type] => 1 [patent_app_number] => 8/702571 [patent_app_country] => US [patent_app_date] => 1996-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1794 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902590.pdf [firstpage_image] =>[orig_patent_app_number] => 702571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733608 [patent_doc_number] => 05698404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Method of predicting fetal membrane rupture based on pro-matrix metalloproteinase-9 (pro-mmp-9)' [patent_app_type] => 1 [patent_app_number] => 8/727883 [patent_app_country] => US [patent_app_date] => 1996-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5653 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698404.pdf [firstpage_image] =>[orig_patent_app_number] => 727883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947082 [patent_doc_number] => 05955285 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Method of identifying individuals at risk of suffering from cerebral amyloidosis' [patent_app_type] => 1 [patent_app_number] => 8/726433 [patent_app_country] => US [patent_app_date] => 1996-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7288 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955285.pdf [firstpage_image] =>[orig_patent_app_number] => 726433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045190 [patent_doc_number] => 05874527 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Plasmodium vivax blood stage antigens' [patent_app_type] => 1 [patent_app_number] => 8/719822 [patent_app_country] => US [patent_app_date] => 1996-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 8897 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874527.pdf [firstpage_image] =>[orig_patent_app_number] => 719822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1217387 [patent_doc_number] => 06706872 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Polynucleotides encoding Plasmodium vivax blood stage antigens' [patent_app_type] => B1 [patent_app_number] => 08/719821 [patent_app_country] => US [patent_app_date] => 1996-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 10167 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706872.pdf [firstpage_image] =>[orig_patent_app_number] => 08719821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939805 [patent_doc_number] => 05989843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein' [patent_app_type] => 1 [patent_app_number] => 8/720420 [patent_app_country] => US [patent_app_date] => 1996-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 70523 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989843.pdf [firstpage_image] =>[orig_patent_app_number] => 720420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828146 [patent_doc_number] => 05711932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Screening procedure for neuroactive agents' [patent_app_type] => 1 [patent_app_number] => 8/718281 [patent_app_country] => US [patent_app_date] => 1996-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5127 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/711/05711932.pdf [firstpage_image] =>[orig_patent_app_number] => 718281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4112249 [patent_doc_number] => 06071493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Method of screening for an agent that inhibits mononuclear phagocyte-plaque component complex formation' [patent_app_type] => 1 [patent_app_number] => 8/717551 [patent_app_country] => US [patent_app_date] => 1996-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 92 [patent_no_of_words] => 22267 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071493.pdf [firstpage_image] =>[orig_patent_app_number] => 717551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804582 [patent_doc_number] => 05854001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Hepatitis C virus fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/710637 [patent_app_country] => US [patent_app_date] => 1996-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13023 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854001.pdf [firstpage_image] =>[orig_patent_app_number] => 710637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218206 [patent_doc_number] => 06040176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Antibodies to ICAM-related protein' [patent_app_type] => 1 [patent_app_number] => 8/714017 [patent_app_country] => US [patent_app_date] => 1996-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 57672 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040176.pdf [firstpage_image] =>[orig_patent_app_number] => 714017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352410 [patent_doc_number] => 06214973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Reshaped human antibody to human medulloblastoma cells' [patent_app_type] => 1 [patent_app_number] => 8/646265 [patent_app_country] => US [patent_app_date] => 1996-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13675 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214973.pdf [firstpage_image] =>[orig_patent_app_number] => 646265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3865570 [patent_doc_number] => 05837460 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Methods of identifying biologically active receptor-binding peptides' [patent_app_type] => 1 [patent_app_number] => 8/712212 [patent_app_country] => US [patent_app_date] => 1996-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 16232 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 389 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837460.pdf [firstpage_image] =>[orig_patent_app_number] => 712212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180479 [patent_doc_number] => 06020189 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Fibroblast growth factor homologous factors (FHFs) and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/705245 [patent_app_country] => US [patent_app_date] => 1996-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 42 [patent_no_of_words] => 22174 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020189.pdf [firstpage_image] =>[orig_patent_app_number] => 705245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000581 [patent_doc_number] => 20070043215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'RECOMBINANT F1-V PLAGUE VACCINE' [patent_app_type] => utility [patent_app_number] => 08/699716 [patent_app_country] => US [patent_app_date] => 1996-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7027 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043215.pdf [firstpage_image] =>[orig_patent_app_number] => 08699716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4120033 [patent_doc_number] => 06126918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Screening assays to identify therapeutic agents for amyloidosis' [patent_app_type] => 1 [patent_app_number] => 8/596184 [patent_app_country] => US [patent_app_date] => 1996-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14182 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/126/06126918.pdf [firstpage_image] =>[orig_patent_app_number] => 596184 [rel_patent_id] =>[rel_patent_doc_number] =>)